First-Line Treatment of HER2-Positive Metastatic Breast Cancer
2 Visninger
• 07/03/23
0
0
Indlejre
administrator
Abonnenter
Panelists discuss the combination of trastuzumab, pertuzumab, and docetaxel as frontline treatment for patients with HER2-positive metastatic breast cancer.
To view more from this discussion, visit http://www.onclive.com/peer-exchange/mbc-community
Vis mere
Facebook kommentarer
SORT BY-
Topkommentarer
-
Seneste kommentarer